Quadrivalent Market 2026 growing strongly, reaching $15.37 billion by 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Quadrivalent Market Between 2026 And 2030?

The quadrivalent market size has experienced significant expansion in recent years. It is anticipated to expand from $9.51 billion in 2025 to $10.44 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.8%. This historical period’s growth can be attributed to the increasing prevalence of influenza, governmental vaccination initiatives, developments in vaccine research, a rise in public awareness regarding flu prevention, and the early adoption of quadrivalent vaccines in developed regions.

The quadrivalent market size is projected to experience substantial growth in the upcoming years. It is foreseen to expand to $15.37 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.1%. The expansion during the forecast period can be attributed to an increasing need for more extensive influenza protection, advancements in vaccine delivery technologies, the broadening of immunization initiatives in developing markets, heightened investments in biotechnology and precision medicine, and supportive reimbursement policies coupled with government backing. Significant trends expected in the forecast period include the refinement of vaccine formulations, the implementation of immunization programs for wider age groups, innovations in cold chain management and distribution, comprehensive multi-strain influenza coverage, and strict adherence to regulatory requirements and quality standards.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9335&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Quadrivalent Market?

The global rise in immunization coverage is projected to advance the quadrivalent market. Immunization coverage defines the percentage of a population that has received specific or recommended vaccines within a set timeframe. Expanding immunization coverage leads to increased demand for vaccines, with quadrivalent vaccines, which offer defense against four strains, often incorporated into regular vaccination programs to combat multiple disease threats in one shot. For instance, in July 2025, the World Health Organization, a Switzerland-based international public health organization, reported that the worldwide coverage for the first dose of the HPV vaccine among girls rose from 27% in 2023 to 31% in 2024. Thus, increasing immunization coverage globally will propel the quadrivalent market’s growth moving forward.

Which Market Segments Are Examined In The Quadrivalent Market Study?

The quadrivalent market covered in this report is segmented –

1) By Type: Intradermal Shot, Intramuscular Injection, Nasal Spray

2) By Technology: Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies

3) By Disease: Cancer, Hepatitis, Pneumococcal Disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs)

Subsegments:

1) By Intradermal Shot: Standard Intradermal Injection, Needle-Free Intradermal Delivery

2) By Intramuscular Injection: Standard Intramuscular Injection, Adjuvanted Intramuscular Injection

3) By Nasal Spray: Live Attenuated Nasal Spray, Inactivated Nasal Spray

Which Trends Are Influencing The Quadrivalent Market?

Key companies within the quadrivalent market are concentrating on developing safer, cutting-edge vaccine delivery methods, such as nano-particle technology, to increase their market revenues. This nano-particle technology imitates the virus’s external form by utilizing virus-like particles (VLPs) that do not contain live genetic material, thereby enhancing both safety and immune system response. For instance, in March 2024, Cadila Pharmaceuticals, an India-based pharmaceutical company, released its advanced Quadrivalent Influenza Vaccine. This sophisticated immunization is specifically designed to offer protection against four distinct strains of the influenza virus, including two A strains (H1N1 and H3N2) and two B strains. This quadrivalent formulation improves the vaccine’s efficacy by targeting a wider array of circulating influenza viruses, making it particularly valuable during flu seasons. The aQIV intends to stimulate a strong immune response, consequently reducing the frequency of influenza-related illness and fatalities. Its development underscores continuous efforts to enhance public health outcomes as viral strains evolve.

Who Are The Primary Competitors In The Quadrivalent Market?

Major companies operating in the quadrivalent market are AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Pfizer Inc., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG)

Read the full quadrivalent market report here:

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

What Are The Leading Geographic Regions In The Quadrivalent Market?

North America was the largest region in the quadrivalent market in 2025. The regions covered in the quadrivalent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Quadrivalent Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9335&type=smp

Browse Through More Reports Similar to the Global Quadrivalent Market 2026, By The Business Research Company

Quadrivalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

Pentavalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Pentavalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795